HLF - HERBALIFE LTD.
7.28
-0.040 -0.549%
Share volume: 2,446,588
Last Updated: 05-05-2025
Wholesale/Wholesale – Drugs & Drug Proprietaries:
0.00%
PREVIOUS CLOSE
CHG
CHG%
$7.32
-0.04
-0.01%
View ratios
| Fiscal Date | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 08-02-2023 | 11-01-2023 | 02-19-2025 | 05-01-2024 | 07-31-2024 | 10-30-2024 | 02-19-2025 | 04-30-2025 | |
| Total revenue | 1.314 B | 1.281 B | 1.215 B | 1.264 B | 1.281 B | 1.240 B | 1.207 B | 1.222 B | |
| Cost of revenue | 301.600 M | 303.200 M | 287.600 M | 285.000 M | 283.100 M | 268.700 M | 267.500 M | 265.200 M | |
| Gross profit | 1.012 B | 978.100 M | 927.400 M | 979.300 M | 998.000 M | 971.600 M | 939.900 M | 956.500 M | |
| -3.39% | -5.18% | 5.60% | 1.91% | -2.65% | -3.26% | 1.77% | |||
| Operating expenses | 460.500 M | 455.300 M | 474.300 M | 492.200 M | 502.300 M | 444.000 M | 436.900 M | 431.900 M | |
| Selling general and admin | 460.500 M | 455.300 M | 474.300 M | 492.200 M | 502.300 M | 444.000 M | 436.900 M | 431.900 M | |
| Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total expenses | 1.192 B | 1.175 B | 871.600 M | 907.400 M | 917.600 M | 844.500 M | 833.400 M | 833.700 M | |
| -1.44% | -25.80% | 4.11% | 1.12% | -7.97% | -1.31% | 0.04% | |||
| Operating income | 122.200 M | 106.700 M | 55.800 M | 71.900 M | 80.400 M | 127.100 M | 106.500 M | 122.800 M | |
| Ebit | 122.200 M | 106.700 M | 55.800 M | 71.900 M | 69.900 M | 127.100 M | 106.500 M | 122.800 M | |
| Pretax income | 85.000 M | 69.200 M | 17.700 M | 34.000 M | 12.200 M | 70.600 M | 52.600 M | 70.800 M | |
| -18.59% | -74.42% | 92.09% | -64.12% | 478.69% | -25.50% | 34.60% | |||
| Income tax | 25.100 M | 26.400 M | 7.500 M | 9.700 M | 7.500 M | 23.200 M | -125.300 M | 20.400 M | |
| Net income basic | 59.900 M | 42.800 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| -28.55% | -100.00% | ||||||||
| Net income | 59.900 M | 42.800 M | 10.200 M | 24.300 M | 4.700 M | 47.400 M | 177.900 M | 50.400 M | |
| -28.55% | -76.17% | 138.24% | -80.66% | 908.51% | 275.32% | -71.67% |
